Opthea Limited (NASDAQ:OPT), a biotechnology company specializing in the development of novel therapeutics for eye diseases, announced today that it will participate in the Oppenheimer Healthcare ...

Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

If you have been looking for Small Cap Growth funds, a place to start could be Oppenheimer Discovery Y (ODIYX). ODIYX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

Robert Downey Jr., Emma Stone, Cillian Murphy and Da'Vine Joy Randolph have been announced as the first group of presenters ...

Albemarle (NYSE:ALB – Get Free Report) was downgraded by research analysts at Evercore ISI from an “outperform” rating to an ...

At the beginning of 2025, South Africa had six billionaires on the global wealth rankings. These individuals have built their ...

Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...

After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...